Tecan and IBBL (Integrated BioBank of Luxembourg) have successfully co-developed an automated platform for buffy coat extraction based on a Freedom EVOŽ 200 workstation.
Lin Xu, Principle Scientist at Biogen Idec, to present "Imaging Drug And Metabolites In Target Tissue Using Ambient Surface Sampling Mass Spectrometry" at the 6th Imaging in Drug Discovery and Development Conference to be held in Boston, MA on May 8-10, 2013 by GTC.
GTC's inaugural Orphan Drugs Research and Commercialization Conference brings together leaders in industry, academia, government, and patient groups to dialogue about strategies to improve orphan drug research, pricing, access, and other key topics. Michael Scott, Chairman of the National Organization of Rare Disorders (NORD) will give a keynote presentation at the Conference.
Samir Patel, President and CEO at Ophthotech To Give a Keynote Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA).
Michael Pellini, President and CEO of Foundation Medicine, Will Be Presenting at GTC's 6th Oncology Biomarkers Conference, Taking Place in San Francisco, CA on March 20-22, 2013.
The Asia Syringe Pump from Syrris, designed specifically for flow chemistry, employs patented pumping technology, giving chemists a tool to perform flow reactions not possible using HPLC pumps or 'single shot' syringe pumps.
Dr. Anne De Groot CEO/CSO EpiVax will present the keynote address at the Inaugural Immunogenicity and Immunotoxicity Conference (Jan 31 - Feb 1, 2013 in San Diego, CA).
Dr. Deshaies is Professor and Executive Officer of Biology at the California Institute of Technology and an Investigator at the Howard Hughes Medical Institute.
Nicholas W. Lukacs, Professor of Pathology and Assistant Dean for Faculty Affairs at the University of Michigan will give a presentation on "Targeting SCF in Chronic Pulmonary Disease" at the 11th Cytokines and Inflammation Conference to be held in San Diego, CA on January 31 - February 1, 2013 by GTC.
Nicholas Dracopoli, Vice President and Head of Oncology Biomarkers at Janssen R&D Will Give a Plenary Keynote Presentation Entitled "Why So Few Companion Diagnostics? The Difficulty of Translating Biological Data into Predictive Biomarkers" at GTC's Biomarker Summit 2013 Taking Place in San Francisco, CA on March 20-22, 2013.
Michael Weiner, Professor of Medicine, Radiology and Psychiatry at UCSF Will Be Giving a Featured Presentation Entitled "Using Imaging and CSF Biomarkers in Clinical Alzheimer's Disease Trials: The Alzheimer's Disease Neuroimaging Initiative (ADNI)" at GTC's 2nd Neurological Biomarkers Conference, Taking Place in San Francisco, CA on March 20-22, 2013.
Jeremy Barton, VP, Head of Oncology Clinical Research at Pfizer to Give a Keynote Presentation at the 4th Cancer Targets & Therapeutics Conference (Feb 25-26, 2013 in Las Vegas, NV).
Jack A. Ragheb, M.D., Ph.D. Principal Investigator at the Laboratory of Immunology in the Division of Therapeutic Proteins Office of Biological Products, CDER, FDA Will Give a Presentation at the Inaugural Immunogenicity and Immunotoxicity Conference on Jan 31 - Feb 1, 2013 in San Diego, CA.
Charles Cantor, Chief Scientific Officer at Sequenom Will Be Giving a Plenary Keynote Presentation Entitled "Non-invasive Personalized Genomics" at GTC's Biomarker Summit 2013, Taking Place in San Francisco, CA on March 20-22, 2013.
Daniel Chan, Professor and Director of Clinical Chemistry Division at John Hopkins University Will Give a Plenary Keynote Presentation at GTC's Biomarker Summit 2013 Taking Place in San Francisco, CA on March 20-22, 2013.
ComplianceOnline, the leading GRC advisory network, and renowned regulatory affairs expert Dr. Nanda Subbarao will conduct a two day seminar on biosimilars analytical.
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
Oxford Expression Technologies (OET), the award-winning specialist provider of baculovirus-based protein expression solutions, announce the launch of flashBACPRIME, the newest edition to the flashBAC range.
Panel Discussion on 'Innovative Partnering & Deal-making in Oncology' Features Panelists from AstraZeneca, Amgen, Endocyte and Pfizer at 2nd Oncology Partnering & Deal-Making Conference (Feb 25-26, 2013 in Las Vegas).
Ronald Swanson, Senior Director, Janssen R&D Will Give a Featured Presentation on "Engineering Novel Therapeutics Targeting the Ion Channel Kv1.3" at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 - Feb 1, 2013 in San Diego, CA)
Thomas Platts-Mills, Division Head of Allergy, Asthma & Immunology at the University of Virginia, will be giving a presentation entitled, "The Significance of IgE Antibodies to Galactose-alpha -1, 3-Galactose (alpha-gal)" at GTC's 2nd Allergy & Respiratory Drug Discovery Conference taking place in San Diego, CA on January 31st - February 1st, 2013.
AdvantaPure(R) has released a new video that details the benefits and uses of AdvantaFlex. The tubing may be sterile welded, heat sealed, and molded into fittings. It is also an excellent choice for peristaltic pumps as it eliminates silicone tubing splices. The video illustrates all of these, points out the tubing's extensive testing, and notes its application suitability.
Steve Swanson, Executive Director and Head of Clinical Immunology at Amgen, will give a featured presentation entitled "Immunogenicity Assessment of Therapeutic Proteins: Where We Are and Where We are Headed", at the Inaugural Immunogenicity and Immunotoxicity conference to be held on Jan 31 - Feb 1, 2013 in San Diego, CA.
Satisfied Users & 
Approved Press Releases
